Exempting User Fees From Sequester Could Take Flight
This article was originally published in The Tan Sheet
Executive Summary
A bipartisan group of House Appropriations Committee members criticize the current policy of FDA user fee revenue being captured by the mandatory budget cuts. FDA Commissioner Margaret Hamburg says losing user fee revenue is “troubling” to the agency and the private sector.
You may also be interested in...
FDA “People Power” Could Take Sequestration Hit – Hamburg
The FDA commissioner says a budget sequester would slow implementation of FDA Safety and Innovation Act provisions and reduce some overseas inspections. More emphasis could be placed on using systems that target the riskiest facilities to reduce the number of onsite inspections, Hamburg says.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.
US FDA Hopes Food, Inspection Office Reorg Bolsters Innovative Clinical Trial Adoption
Ensuring inspectors understand the innovative trial designs in use before an inspection will be important to increasing industry confidence in their use, CDER Director Patrizia Cavazzoni said.